Pancreatic Cancer Research

ResearcherUniversity of California San DiegoNo recent work listed

Michele L. Babicky

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2917-2730; OpenAlex author ID A5014465006. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper

Papers 4

  1. MST1R kinase accelerates pancreatic cancer progression via effects on both epithelial cells and macrophages. Co-author DOI 10.1038/s41388-019-0811-9↗
  2. Characterization of RON protein isoforms in pancreatic cancer: implications for biology and therapeutics. Co-author DOI 10.18632/oncotarget.10009↗
  3. The RON receptor tyrosine kinase in pancreatic cancer pathogenesis and its potential implications for future targeted therapies. First author DOI 10.1097/mpa.0000000000000088↗
  4. The RON-receptor regulates pancreatic cancer cell migration through phosphorylation-dependent breakdown of the hemidesmosome. First author DOI 10.1002/ijc.27447↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrew M. Lowy · 4 shared papers, 2012–2019 · strength 0.22
  2. Dawn Jaquish · 3 shared papers, 2012–2019 · strength 0.15
  3. Jeffery M. Chakedis · 2 shared papers, 2016–2019 · strength 0.12
  4. Alex Cazes · 1 shared paper, 2019 · strength 0.07
  5. Betzaira G. Childers · 1 shared paper, 2019 · strength 0.07
  6. Philippe Foubert · 1 shared paper, 2019 · strength 0.07
  7. Megan M. Harper · 1 shared paper, 2019 · strength 0.07
  8. Michael C. Schmid · 1 shared paper, 2019 · strength 0.07
  9. Judith A. Varner · 1 shared paper, 2019 · strength 0.07
  10. Chang Moo Kang · 1 shared paper, 2014 · strength 0.07
  11. David A Cheresh · 1 shared paper, 2012 · strength 0.03
  12. Peter T. Yu · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.